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Introduction
Aberrant inflammasome priming and dysregulated secre-
tory pathways contribute to parallel IL-18 and S100A12
hypersecretion from neutrophils in instable FMF.
Objectives
The study was performed to assess the ex vivo inflamma-
some activity in granulocytes from patients with unstable
FMF. Furthermore, the secretion of S100A12 molecules
after various kinds of cell stimulation was assessed.
Methods
6 turkish patients with the clinical diagnosis of FMF
exhibiting homocygous or combined heterozygous muta-
tions within the MEFV gene were included. Patients still
exhibited clinical symptoms and elevated inflammation
markers despite sufficient colchicine therapy (“instable
disease”). Healthy probands served as controls. Their
health status was assessed by a standardized questionnaire.
All patients and controls gave written consent.
25 – 30 ml blood was drawn and PBMC and granulo-
cytes separated by a two density gradient centrifugation.
5 x 106 cells were stimulated with (i) mock, (ii) PMA
(10nM), (iii) LPS (10ng/ml) and (iv) LPS (10ng/ml) + ATP
(1mM) (later substance for the last 30 minutes). In a simi-
lar approach cells were treated with additional colchicine
(5μg/ml) for the whole incubation time. Supernatant was
gained and frozen at -20oC after 5 hours. ELISA for
S100A12, IL-18 and caspase-1 were performed according
to standard protocols.
At the time of blood drawing high sensitivity CRP was
measured.
Results
Compared to controls even unstimulated granuloytes from
FMF patients with instable disease secreted significantly
more S100A12 (mean controls 43ng/ml vs. mean patients
327ng/ml, p <.01), IL-18 (0pg/ml vs. 274pg/ml, p <.01)
and caspase-1 (10pg/ml vs. 81pg/ml, p <.01). Stimulation
also induced enhanced secretion of S100A12 (PMA:
61ng/ml vs. 336ng/ml, p <.01; LPS: 74ng/ml vs. 247ng/ml,
p <.01; LPS/ATP: 94ng/ml vs. 252ng/ml, p <.01), IL-18
(LPS: 3,6pg/ml vs 176pg/ml, p <.05; LPS/ATP: 7pg/ml vs.
198pg/ml, p <.05) and caspase-1 (LPS: 23pg/ml vs.
72pg/ml, p <.01; LPS/ATP: 32pg/ml vs. 69pg/ml, p <.05).
Furthermore, supplementary colchicine significantly
suppressed the hypersecretion of S100A12, IL-18 and
caspase-1.
Conclusion
The spontaneous release of IL-18 and caspase-1 demon-
strated the constant inflammasome activity in patients
with instable FMF. It was not be further induced by LPS/
ATP stimulation. S100A12, although not processed by the
inflammasome, was also secreted in high amount from
FMF neutrophils, irrespective of further stimulation.
Taken together, these data indicate that FMF neutrophils
show a spontaneous hypersecretion of S100A12 and IL-18
which is only partially related to aberrant inflammasome
activation (shown by parallel Caspase-1 release) but may
also dependent on dysregulated alternative secretion
(inhibited by colchicine in vitro).
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